Aminergic G protein-coupled receptor panel

The broader aminergic receptor panel refers to a diverse group of G protein-coupled receptors (GPCRs) that are activated by biogenic amines, including dopamine, serotonin, norepinephrine, epinephrine, and histamine (IUPHAR/BPS Guide to PHARMACOLOGY). These receptors are critical mediators of signal transduction in the central and peripheral nervous systems, regulating essential processes such as mood, cognition, cardiovascular function, and the immune response (Nature Reviews Drug Discovery, 2012). In the context of drug development, this panel is frequently used in safety pharmacology and secondary pharmacology profiling to identify potential off-target activities of lead compounds (Bowes et al., 2012). Many neuropsychiatric drugs, particularly atypical antipsychotics and antidepressants, are characterized by their multi-receptor binding profiles across this panel, which contributes to both their therapeutic efficacy and their side-effect profiles (StatPearls, 2023). Understanding the interaction of a molecule with the broader aminergic panel is vital for predicting clinical outcomes and managing risks such as metabolic disturbances or cardiovascular toxicity.

Other names

Biogenic amine receptorsAminergic GPCRsMonoamine receptorsAminergic receptor panel

Drugs typically act as agonists, antagonists, or inverse agonists at various members of this receptor panel to modulate neurotransmission or physiological responses.